pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

3,256 catalysts · 3,086 8k filing · 2,096 grant · 1,160 approval · 1,000 device adverse event · 874 device 510k · 623 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 57 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×from 2026-01-06×clear all
type
  • 8k filing3,086
  • grant2,096
  • approval1,160
  • device adverse event1,000
  • device 510k874
  • device pma623
earnings
583
  • device recall403
  • recall220
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 5, 2026

    50
    ›Jan 6, 2026approval218d agoOLOPATADINE HYDROCHLORIDE — FDA approvalPataday

    Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Pataday →fda approvals ↗
    ›Jan 6, 2026approval218d agoCIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN) — FDA approvalBedford Laboratories

    Sponsor: UPSHER SMITH LABS. Form: SUSPENSION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: SANALUZ. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Jan 6, 2026approval218d agoMECLIZINE HYDROCHLORIDE — FDA approvalMECLIZINE HYDROCHLORIDE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →MECLIZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 6, 2026approval218d agoAMONDYS 45 (CASIMERSEN) — FDA approvalcasimersen

    Sponsor: SAREPTA THERAPS INC. Form: SOLUTION. Route: INTRAVENOUS

    full page →casimersen →fda approvals ↗
    ›Jan 6, 2026approval218d agoBORTEZOMIB — FDA approvalBortezomib Pfizer

    Sponsor: GLAND. Form: POWDER. Route: INTRAVENOUS, SUBCUTANEOUS

    full page →Bortezomib Pfizer →fda approvals ↗
    ›Jan 6, 2026approval218d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

    Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION

    full page →ROCURONIUM BROMIDE →fda approvals ↗
    ›Jan 6, 2026grant218d agoUNIVERSITY OF WASHINGTON — Real-time imaging of opioid neuromodulation with novel genetically encoded fl...University of Washington

    DA grant. $49,538. PI: Lily Torp

    full page →nih reporter ↗
    ›Jan 6, 2026grant218d agoOREGON HEALTH & SCIENCE UNIVERSITY — Metabolic coupling of oligodendroglia and endothelial cells through cell-spec...

    NS grant. $74,632. PI: THADDEUS KUNKEL

    full page →nih reporter ↗
    ›Jan 6, 2026grant218d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Polarity dysregulation in Alzheimer’s disease

    NS grant. $50,000. PI: Huaye Zhang

    full page →nih reporter ↗
    ›Jan 7, 2026approval217d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 7, 2026approval217d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 7, 2026approval217d agoQUETIAPINE FUMARATE — FDA approvalquetiapine fumarate ER

    Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

    full page →quetiapine fumarate ER →fda approvals ↗
    ›Jan 7, 2026approval217d agoENOXAPARIN SODIUM (PRESERVATIVE FREE) (ENOXAPARIN SODIUM) — FDA approvalShenzhen Techdow Pharmaceutical Co Ltd

    Sponsor: HEBEI CHANGSHAN. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Jan 7, 2026approval217d agoPROTRIPTYLINE HYDROCHLORIDE — FDA approvalPROTRIPTYLINE HYDROCHLORIDE

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →PROTRIPTYLINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 7, 2026approval217d agoYESINTEK (USTEKINUMAB-KFCE) — FDA approvalustekinumab biosimilar

    Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

    full page →ustekinumab biosimilar →fda approvals ↗
    ›Jan 7, 2026approval217d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 7, 2026approval217d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 7, 2026approval217d agoNORGESTIMATE AND ETHINYL ESTRADIOL (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: MYLAN. Form: TABLET. Route: ORAL-28

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Jan 7, 2026approval217d agoLEVOCETIRIZINE DIHYDROCHLORIDE — FDA approvalLEVOCETIRIZINE DIHYDROCHLORIDE

    Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL

    full page →LEVOCETIRIZINE DIHYDROCHLORIDE →fda approvals ↗
    ›Jan 7, 2026approval217d agoMETOLAZONE — FDA approvalMETOLAZONE

    Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

    full page →METOLAZONE →fda approvals ↗
    ›Jan 7, 2026grant217d agoWEILL MEDICAL COLL OF CORNELL UNIV — RNA's Role in Double-Strand Break Repair

    CA grant. $49,538. PI: Hina Shah

    full page →nih reporter ↗
    ›Jan 7, 2026grant217d agoWEST VIRGINIA UNIVERSITY — Proteasome function in neurodegenerative disease

    NS grant. $567,047. PI: David Matthew Smith

    full page →nih reporter ↗
    ›Jan 8, 2026approval216d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

    Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

    full page →ensartinib hydrochloride →fda approvals ↗
    ›Jan 8, 2026approval216d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval216d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval216d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Jan 8, 2026approval216d agoSAPROPTERIN DIHYDROCHLORIDE — FDA approvalSAPROPTERIN DIHYDROCHLORIDE

    Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

    full page →SAPROPTERIN DIHYDROCHLORIDE →fda approvals ↗
    ›Jan 8, 2026approval216d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Jan 8, 2026approval216d agoMAGNESIUM SULFATE — FDA approvalMAGNESIUM SULFATE

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

    full page →MAGNESIUM SULFATE →fda approvals ↗
    ›Jan 8, 2026approval216d agoFLUCONAZOLE — FDA approvalDiflucan

    Sponsor: FDC LTD. Form: TABLET. Route: ORAL

    full page →Diflucan →fda approvals ↗
    ›Jan 8, 2026approval216d agoFUROSEMIDE — FDA approvalFurosemide Sun

    Sponsor: MICRO LABS. Form: INJECTABLE. Route: INJECTION

    full page →Furosemide Sun →fda approvals ↗
    ›Jan 8, 2026approval216d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 8, 2026grant216d agoALASKA NATIVE TRIBAL HEALTH CONSORTIUM — Traditional foods and health: A Community-Based Approach to Improving Food Se...

    GM grant. $140,056. PI: Ruby Fried

    full page →nih reporter ↗
    ›Jan 9, 2026approval215d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Jan 9, 2026approval215d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

    Sponsor: ABHAI LLC. Form: SOLUTION. Route: ORAL

    full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
    ← prev
    page 1 of 66
    next →
    $AMRX17.47-2.29%
    $IGC0.2670+0.41%
    $AMRX17.47-2.29%
    $AMRX17.47-2.29%
    $SRPT17.18+2.38%
    $LLY1231.94+3.90%
    $LLY1231.94+3.90%
    $IGC0.2670+0.41%
    $HCWB
    $AMRX17.47-2.29%